Table 1 Patient characteristics (N = 36)
Characteristics | No. (%) |
|---|---|
Age, years | |
 Median (range) | 53 (27–75) |
  < 65 | 28 (77.8) |
  ≥ 65 | 8 (22.2) |
Sex | |
 Male | 21 (58.3) |
 Female | 15 (41.7) |
ECOG performance status | |
 0 | 2 (5.6) |
 1 | 33 (91.7) |
 2 | 1 (2.8) |
Weight, kg, median (range) | 57.0 (39.0–77.0) |
Cancer type | |
 Colorectal | 30 (83.3) |
 Gastric | 6 (16.7) |
Stage at diagnosis | |
 Synchronous metastasis | 28 (77.8) |
 Metachronous metastasis | 8 (22.2) |
Prior chemotherapy | |
 Yes | 7 (19.4) |
 No | 29 (80.6) |
Previous surgery to the primary site | |
 Yes | 19 (52.8) |
 No | 17 (47.2) |
Add Avastin | |
 Yes | 14 (38.9) |
 No | 22 (61.1) |
RAS and BRAF status | |
 KRAS mutant | 10 (27.8) |
 BRAF V600E mutant | 2 (5.6) |
 RAS and BRAF wild-type | 14 (38.9) |
 Unknown | 10 (27.8) |